当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析

拓新药业

(301089)

  

流通市值:29.26亿  总市值:40.70亿
流通股本:9097.63万   总股本:1.27亿

拓新药业(301089)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.30亿元,每股收益-0.24元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益152235.90万元,未分配利润70727.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产168936.52万元,负债16700.62万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入271,553,589.37181,899,752.2496,994,677.03421,694,066.41
营业总成本309,371,817.19202,283,727.81104,540,673.11444,664,721.27
其他经营收益
营业利润-36,358,174.92-21,055,816.67-3,734,479.32-23,718,174.77
利润总额-36,509,622.16-21,431,330.9-3,968,270.53-27,732,486.49
净利润-30,161,076.91-18,280,549.55-3,564,740.69-19,884,868.92
每股收益
其他综合收益---769,185.76
综合收益总额-30,161,076.91-18,280,549.55-3,564,740.69-19,115,683.16
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计608,393,641.46634,513,245.48671,009,370.01677,012,163.72
非流动资产:
非流动资产合计1,080,971,520.261,072,716,734.681,080,684,350.921,081,231,768.33
资产总计1,689,365,161.721,707,229,980.161,751,693,720.931,758,243,932.05
流动负债:
流动负债合计129,843,277.47133,598,574.27162,275,278.24165,324,546.01
非流动负债:
非流动负债合计37,162,900.7239,391,89540,463,122.9440,399,325.6
负债合计167,006,178.19172,990,469.27202,738,401.18205,723,871.61
所有者权益(或股东权益):
归属于母公司股东权益合计1,522,358,983.531,534,239,510.891,548,955,319.751,552,520,060.44
股东权益合计1,522,358,983.531,534,239,510.891,548,955,319.751,552,520,060.44
负债和股东权益合计1,689,365,161.721,707,229,980.161,751,693,720.931,758,243,932.05
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计245,742,038.62161,046,801.0774,063,631.8418,069,930.27
经营活动现金流出小计268,531,622184,061,436.17102,074,168.5315,401,229.35
经营活动产生的现金流量净额-22,789,583.38-23,014,635.1-28,010,536.7102,668,700.92
投资活动产生的现金流量:
投资活动现金流入小计728,911,595.04472,578,804.38341,887,265.55614,036,224.11
投资活动现金流出小计704,571,342.54453,597,614.98230,644,850.83753,912,345.51
投资活动产生的现金流量净额24,340,252.518,981,189.4111,242,414.72-139,876,121.4
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计1,224,188.16--32,572,923.21
筹资活动产生的现金流量净额-1,224,188.16---32,572,923.21
汇率变动对现金及现金等价物的影响-154,322.2131,607.96183,629.72828,794.44
现金及现金等价物净增加额172,158.76-3,901,837.7483,415,507.74-68,951,549.25
期末现金及现金等价物余额61,953,892.0157,879,895.51145,197,240.9961,781,733.25
补充资料:
现金及现金等价物的净增加额--3,901,837.74--68,951,549.25
TOP↑